Correlation Between BRIM Biotechnology and Shanghai Commercial

Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and Shanghai Commercial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and Shanghai Commercial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BRIM Biotechnology and Shanghai Commercial Savings, you can compare the effects of market volatilities on BRIM Biotechnology and Shanghai Commercial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of Shanghai Commercial. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and Shanghai Commercial.

Diversification Opportunities for BRIM Biotechnology and Shanghai Commercial

-0.88

Correlation Coefficient

BRIM Biotechnology  Shanghai Commercial

Pay attention - limited upside

The 3 months correlation between BRIM and Shanghai is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and Shanghai Commercial Savings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Commercial and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with Shanghai Commercial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Commercial has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and Shanghai Commercial go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and Shanghai Commercial

Assuming the 90 days trading horizon BRIM Biotechnology is expected to generate 0.38 times more return on investment than Shanghai Commercial. However, BRIM Biotechnology is 2.63 times less risky than Shanghai Commercial. It trades about 0.72 of its potential returns per unit of risk. Shanghai Commercial Savings is currently generating about 0.04 per unit of risk. If you would invest  2,980  in BRIM Biotechnology on December 10, 2024 and sell it today you would earn a total of  35.00  from holding BRIM Biotechnology or generate 1.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	25.0%
Values	Daily Returns

BRIM Biotechnology  vs.  Shanghai Commercial Savings

BRIM Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Shanghai Commercial

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Commercial Savings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Shanghai Commercial may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with BRIM Biotechnology and Shanghai Commercial

The main advantage of trading using opposite BRIM Biotechnology and Shanghai Commercial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, Shanghai Commercial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Commercial will offset losses from the drop in Shanghai Commercial's long position.

The idea behind BRIM Biotechnology and Shanghai Commercial Savings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.